Yorkville Advisors Global, LP
Position in NRSN — NeuroSense Therapeutics Ltd.
CIK 1838613
Mountainside, NJ
Position in NRSN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$58,890
-$18,010 QoQ
Shares Held
78,000
-22.0% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRSN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Yorkville Advisors Global, LP holds $107,394 across 2 Biotechnology names. NRSN ranks #1 (54.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NRSN |
NeuroSense Therapeutics Ltd.
This page
|
78,000 | $58,890 | |
| 2 | JUNS |
Jupiter Neurosciences, Inc.
|
129,000 | $48,504 |
All Filings in NRSN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,890 | 78,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $76,900 | 100,000 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $113,400 | 60,000 | Shares | Sole | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||